-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Characteristics and Application Prospects of 3D Organoid Platforms
Author:
InnoModels
Release time:
2024-06-20
With the rapid development of biotechnology, scientists are becoming increasingly sophisticated in their understanding and simulation of the complex structures inside living organisms. With its advanced 3D organoid platform, InnoModels Biotechnology provides us with an unprecedented way to study the various organ structures of living organisms. The characteristics of this platform are not only in its ability to highly simulate the real conditions of living organisms, but also in its wide range of applications and powerful experimental capabilities.
First of all, the 3D organoid platform of InnoModels Biotechnology has the feature of multi-cell type support. This feature enables the platform to simulate a variety of complex organ structures, including but not limited to liver, heart and lungs. By introducing multiple cell types, this platform is able to reconstruct structures that are closer to the internal environment of real organisms, providing scientists with a broader scope of research. Whether it is the study of disease mechanisms or the evaluation of drug effects, this support of multiple cell types makes the experiments more accurate and reliable.
Secondly, 3D organoid platform of InnoModels Biotechnology excels in physiological function restoration. The platform is able to simulate the physiological functions of organoids through well-designed culture conditions and support structures, making them closer to the biological properties of organs in the body. This reduction not only enhances the reliability of experimental results, but also makes the platform an ideal tool for disease modeling research. Scientists can utilize this platform to study the development process of diseases and the therapeutic effects of drugs on diseases, providing strong support for future medical research and treatment.

Furthermore, the 3D organoid platform of InnoModels Biotechnology also features high-throughput screening. High-throughput screening is a crucial part of the drug development and evaluation process. This platform can support a large number of experiments at the same time, which greatly improves the experimental efficiency and shortens the time of drug development and evaluation. At the same time, due to the high degree of simulation of this platform, the experimental results are also more informative, helping scientists to more accurately assess the effectiveness and safety of drugs.
In addition, it is worth mentioning that the 3D organoid platform of InnoModels Biotechnology is also highly customizable and scalable. Scientists can customize the culture conditions and cell types according to specific research needs, thus creating organoids with specific physiological properties. Meanwhile, as technology advances, the platform is also expected to support a wider variety of cell types and more complex organoid structures, providing more possibilities for future scientific research.
Overall, the 3D organoid platform of InnoModels Biotechnology shows strong application potential and prospects with its features of multi-cell type support, physiological function reduction and high-throughput screening. It can not only be used for research on disease mechanisms and evaluation of drug effects, but also provide strong support for biomedical engineering, regenerative medicine and other fields. In the future, with the further development and improvement of the technology, we have reason to believe that the 3D organoid platform of InnoModels will play an even more important role in scientific research and medical practice.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd